DRTS
Alpha Tau Medical Ltd.
stockNASDAQ
alpha tau medical (http://www.alphataumedical.com/) focuses on research, development and commercialization of alpha dart (diffusing alpha-emitters radiation therapy) for the treatment of solid cancer tumors. alpha dart technology, initially developed at tel aviv university, was shown to be effective and safe for treating different types of cancer in multiple animal studies. the company is running its first clinical trial in several sites in the eu. breakthrough technology for cancer treatment the alpha dart breakthrough technology utilizes alpha radiation to treat cancer and enables highly potent and conformal radiotherapy. alpha dart treats solid tumors with interstitial radioactive seeds that continually release short-lived alpha emitting atoms into the tumor.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 15.04 | 2026-09-28 | -0.80% | 2.173 |
| 1M | 15.03 | 2026-09-04 | -0.73% | 0.819 |
| 3M | 13.58 | 2026-07-06 | +9.91% | 1.327 |
| 6M | 6.83 | 2026-04-06 | +118.45% | 1.560 |
| 1Y | 4.22 | 2025-10-06 | +253.56% | 2.082 |
| 2Y | 2.28 | 2024-10-04 | +554.39% | — |
| 5Y | 9.13 | 2022-03-09 | +63.42% | 0.681 |
Alpha Tau Medical Ltd. (NASDAQ:DRTS) stock price today is $14.92, and today's volume is 192,589. DRTS is up 1.016% today. The 30 day average volume is 583,464. DRTS market cap is $1.38B with 92.48M shares outstanding.